Track topics on Twitter Track topics that are important to you
LOVELAND, Colo., July 20, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity 37th Annual Growth Conference at 9 a.m. ET on Thursday, August 10, 2017.
The conference will be held August 9-10, 2017 at the InterContinental Boston Hotel in Boston, Mass.
A live webcast of the group presentation will be available at http://wsw.com/webcast/canaccord26/hska. This webcast will be archived for 90 days following the live presentation. Management will be available during the day on August 10 for one-on-one meetings. To schedule a one-on-one meeting, please contact Hayden IR at firstname.lastname@example.org.
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
SOURCE Heska CorporationNEXT ARTICLE
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...